Wake is a bioscience company focused on mental health and wellness.
Wake
Wake’s mission is to leverage discoveries in biosciences to create groundbreaking therapeutics that help transform human health.
Wake is producing federally approved, lab-verified organic medicinal mushrooms and products. Additionally, they are bio-engineering enzymatic modifiers for psychedelic compounds and developing a genetics-based research initiative for the safe administration of psychedelic-assisted psychotherapy.
Wake are currently building a manufacturing facility in Jamaica. Their pipeline includes exploring the potential of microdosing psilocybin for anxiety, depression and PTSD through clinical trials.
“Helping humans transform themselves with medicinal + psychedelic fungi therapy and genomics-based integration”
Activities
B2B
B2C
Pharmaceutical
Biotech
Explore more company info with a Tree membership
📰 Weekly newsletter about the business of psychedelics
📈 Extended company information (analyst view, fundraising, revenue numbers)
🪄 Priority company page updates